For help on how to get the results you want, see our search tips.
1447 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Opinions on maximum residue limits Remove Opinions on maximum residue limits filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Xtandi (updated)
enzalutamide, Prostatic Neoplasms
Date of authorisation: 21/06/2013,
Date of refusal: 26/04/2013, Revision: 18, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Copalia (updated)
valsartan, amlodipine (as amlodipine besilate), Hypertension
Date of authorisation: 15/01/2007, Revision: 25, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Lamivudine Teva Pharma B.V. (updated)
lamivudine, HIV Infections
Date of authorisation: 10/12/2009,
, Revision: 15, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Arsenic trioxide Accord (updated)
Arsenic trioxide, Leukemia, Promyelocytic, Acute
Date of authorisation: 14/11/2019,, Revision: 3, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Ziextenzo (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 22/11/2018,
, 
, Revision: 3, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Fycompa (updated)
perampanel, Epilepsies, Partial
Date of authorisation: 23/07/2012, Revision: 22, Authorised, Last updated: 12/05/2021 -
List item
Human medicine European public assessment report (EPAR): Nustendi (updated)
Bempedoic acid, Ezetimibe, Hypercholesterolemia, Dyslipidemias
Date of authorisation: 27/03/2020,, Revision: 3, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Memantine Merz (updated)
memantine hydrochloride, Alzheimer Disease
Date of authorisation: 22/11/2012, Revision: 7, Authorised, Last updated: 11/05/2021 -
List item
Human medicine European public assessment report (EPAR): Deltyba (updated)
Delamanid, Tuberculosis, Multidrug-Resistant
Date of authorisation: 27/04/2014,
Date of refusal: 25/07/2013,, 
, 
, Revision: 16, Authorised, Last updated: 11/05/2021
-
List item
Human medicine European public assessment report (EPAR): Ruxience (updated)
rituximab, Leukemia, Lymphocytic, Chronic, B-Cell, Arthritis, Rheumatoid, Microscopic Polyangiitis, Pemphigus
Date of authorisation: 01/04/2020,, , Revision: 3, Authorised, Last updated: 11/05/2021
-
List item
Human medicine European public assessment report (EPAR): Otezla (updated)
apremilast, Arthritis, Psoriatic, Psoriasis
Date of authorisation: 15/01/2015, Revision: 15, Authorised, Last updated: 11/05/2021 -
List item
Human medicine European public assessment report (EPAR): Xadago (updated)
safinamide methanesulfonate, Parkinson Disease
Date of authorisation: 23/02/2015, Revision: 11, Authorised, Last updated: 11/05/2021 -
List item
Human medicine European public assessment report (EPAR): Eliquis (updated)
Apixaban, Arthroplasty, Venous Thromboembolism
Date of authorisation: 18/05/2011,
, Revision: 25, Authorised, Last updated: 11/05/2021
-
List item
Human medicine European public assessment report (EPAR): Feraccru (updated)
ferric maltol, Anemia, Iron-Deficiency
Date of authorisation: 18/02/2016, Revision: 13, Authorised, Last updated: 11/05/2021 -
List item
Human medicine European public assessment report (EPAR): Vantavo (previously Alendronate sodium and colecalciferol, MSD) (updated)
alendronic acid, colecalciferol, Osteoporosis, Postmenopausal
Date of authorisation: 16/10/2009, Revision: 16, Authorised, Last updated: 11/05/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Apoquel (updated)
oclacitinib maleate, Dogs
Date of authorisation: 12/09/2013, Revision: 7, Authorised, Last updated: 10/05/2021 -
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)
pregabalin, Anxiety Disorders, Neuralgia, Epilepsy
Date of authorisation: 19/06/2015,, Revision: 6, Authorised, Last updated: 10/05/2021
-
List item
Human medicine European public assessment report (EPAR): Kyprolis (updated)
carfilzomib, Multiple Myeloma
Date of authorisation: 19/11/2015,
, , Revision: 19, Authorised, Last updated: 07/05/2021
-
List item
Human medicine European public assessment report (EPAR): COVID-19 Vaccine Moderna (updated)
CX-024414 (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2), COVID-19 virus infection
Date of authorisation: 06/01/2021,, , Revision: 2, Authorised, Last updated: 12/05/2021
-
List item
Human medicine European public assessment report (EPAR): Lenalidomide Accord (updated)
lenalidomide, Multiple Myeloma
Date of authorisation: 20/09/2018,, Revision: 6, Authorised, Last updated: 07/05/2021
-
List item
Human medicine European public assessment report (EPAR): Volibris (updated)
ambrisentan, Hypertension, Pulmonary
Date of authorisation: 20/04/2008, Revision: 21, Authorised, Last updated: 07/05/2021 -
List item
Human medicine European public assessment report (EPAR): Ketoconazole HRA (updated)
Ketoconazole, Cushing Syndrome
Date of authorisation: 18/11/2014,, , , Revision: 10, Authorised, Last updated: 07/05/2021
-
List item
Human medicine European public assessment report (EPAR): Vaborem (updated)
meropenem trihydrate, vaborbactam, Urinary Tract Infections, Bacteremia, Bacterial Infections, Respiratory Tract Infections, Pneumonia, Pneumonia, Ventilator-Associated
Date of authorisation: 20/11/2018,, Revision: 4, Authorised, Last updated: 07/05/2021
-
List item
Human medicine European public assessment report (EPAR): Trizivir (updated)
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 37, Authorised, Last updated: 07/05/2021 -
List item
Human medicine European public assessment report (EPAR): Myocet liposomal (previously Myocet) (updated)
doxorubicin hydrochloride, Breast Neoplasms
Date of authorisation: 13/07/2000, Revision: 23, Authorised, Last updated: 07/05/2021